Download PDFPDF

758 A phase 1 dose escalation and expansion study of the anti-CD200R1 antibody 23ME-00610 in patients with advanced solid malignancies
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address